{"organizations": [], "uuid": "81d96697bbcc03283a0922f75f55e5793569e4af", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180508.html", "section_title": "Archive News &amp; Video for Tuesday, 08 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-amicus-therapeutics-reports-q1-los/brief-amicus-therapeutics-reports-q1-loss-per-share-of-0-28-idUSASC0A0ES", "country": "US", "domain_rank": 408, "title": "BRIEF-Amicus Therapeutics Reports Q1 Loss Per Share Of $0.28", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.053, "site_type": "news", "published": "2018-05-08T19:25:00.000+03:00", "replies_count": 0, "uuid": "81d96697bbcc03283a0922f75f55e5793569e4af"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-amicus-therapeutics-reports-q1-los/brief-amicus-therapeutics-reports-q1-loss-per-share-of-0-28-idUSASC0A0ES", "ord_in_thread": 0, "title": "BRIEF-Amicus Therapeutics Reports Q1 Loss Per Share Of $0.28", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "amicus therapeutics inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "ial", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 8 (Reuters) - Amicus Therapeutics Inc:\n* AMICUS THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND CORPORATE UPDATES\n* Q1 LOSS PER SHARE $0.28 * Q1 REVENUE $16.7 MILLION VERSUS I/B/E/S VIEW $16.9 MILLION\n* SEES FY 2018 REVENUE $75 MILLION TO $85 MILLION * Q1 EARNINGS PER SHARE VIEW $-0.36 â€” THOMSON REUTERS I/B/E/S\n* REAFFIRMS FY18 REVENUE GUIDANCE OF $75M-$85M AT TOP END OF RANGE\n* CONTINUES TO EXPECT FULL-YEAR 2018 NET CASH SPEND BETWEEN $230 MILLION AND $260 MILLION\n* CURRENT CASH POSITION, OTHER PROCEEDS, SUFFICIENT TO FUND ONGOING FABRY AND POMPE PROGRAM OPERATIONS INTO AT LEAST 2021\n* CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES $605.2 MILLION AT MARCH 31, 2018, VERSUS $358.6 MILLION AT DECEMBER 31, 2017 Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-08T19:25:00.000+03:00", "crawled": "2018-05-09T12:49:25.000+03:00", "highlightTitle": ""}